Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.240
-0.220 (-8.94%)
At close: Apr 28, 2026, 4:00 PM EDT
2.410
+0.170 (7.59%)
Pre-market: Apr 29, 2026, 8:35 AM EDT
Lantern Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 25 | 34 | 34 | 47 | 66 | 89 | |
| Market Cap Growth | -27.47% | -1.49% | -26.05% | -29.06% | -26.55% | -25.41% | |
| Enterprise Value | 15 | 22 | 7 | 2 | 8 | 16 | |
| Last Close Price | 2.24 | 3.03 | 3.19 | 4.28 | 6.04 | 7.98 | |
| PB Ratio | 3.86 | 5.19 | 1.62 | 1.14 | 1.17 | 1.25 | |
| P/TBV Ratio | 3.84 | 5.19 | 1.62 | 1.14 | 1.17 | 1.25 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | |
| Net Debt / Equity Ratio | -1.54 | -1.54 | -1.12 | -1.00 | -0.98 | -0.98 | |
| Net Debt / EBITDA Ratio | 0.56 | 0.56 | 1.07 | 2.30 | 3.82 | 6.09 | |
| Net Debt / FCF Ratio | 0.64 | 0.64 | 1.33 | 2.86 | 4.31 | 6.65 | |
| Quick Ratio | 2.26 | 2.26 | 5.57 | 15.74 | 19.94 | 30.48 | |
| Current Ratio | 2.40 | 2.40 | 5.83 | 16.18 | 20.99 | 31.26 | |
| Return on Equity (ROE) | -123.51% | -123.51% | -66.93% | -32.93% | -22.35% | -27.09% | |
| Return on Assets (ROA) | -61.39% | -61.39% | -40.12% | -21.80% | -13.59% | -15.36% | |
| Return on Capital Employed (ROCE) | -275.10% | -275.10% | -104.60% | -43.60% | -25.80% | -16.20% | |
| Earnings Yield | -68.18% | -50.52% | -60.41% | -34.31% | -21.75% | -13.85% | |
| FCF Yield | -62.44% | -46.27% | -51.81% | -30.88% | -19.51% | -11.88% | |
| Buyback Yield / Dilution | -1.26% | -1.26% | 0.74% | 0.08% | 0.50% | -153.31% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.